Korean Pharma Stocks Rise as Prombio Resumes Trading After Stock Split
On August 10, 2026, South Korea’s domestic pharmaceutical and biotech equities surged, bolstered by a technical rebound in the Kosdaq index. FromBio (KOSDAQ: 377220) hit the daily ceiling price immediately ... Read More